About ZirChrom Separations
ZirChrom Separations is a Healthcare company based in Anoka (United States) founded in 1995. Zirconia-based HPLC stationary phases are developed for LC-MS compatibility. Its chief executive, as recorded, is Clayton McNeff. ZirChrom Separations offers products and services including ZirChrom Phases, Buffer Wizard Software, and HPLC Columns. Its focus areas include Life Sciences, Life Sciences Platforms and Tools, Instruments and Chromatography. Its legal entity is ZirChrom Separations, Inc. Its competitors include ChromaTan, Sepax Technologies and Semba Biosciences; 3 of its 3 listed competitors have raised funding.
Company details
ZirChrom Separations is developing and manufacturing Zirconia-based HPLC stationary phases which can be used for analyzing non-volatile compounds in a range of industries. The companys HPLC stationary phases are LC-MS friendly and are ultra-durable zirconia and titania-based and as per company claims, offer unique chromatographic selectivity and high efficiency, low back pressure and excellent pore structure of rigid inorganic supports. The company claims that unlike traditional Silica gel, alumina or polymeric HPLC stationary phases, their Zirconia-based columns are chemically stable over the entire pH range from 1-14, and are also thermally stable. The companys HPLC columns can be used for the analysis of amino acids, peptides, proteins, nucleic acids (RNA and DNA), carbohydrates, pesticides, environmental samples, clinical samples and pharmaceuticals, and others.
- Headquarters Anoka, United States
- SectorsHealthcare
- Email••••••••
- Phone•••• ••••
- Website zirchrom.com
- Social LinkedIn
- Legal Name Zirchrom Separations, Inc.
- Latest Funding Round$350K (USD), Grant
Aug 2001
- InvestorsNIH
& 1 more
Products & Services of ZirChrom Separations
ZirChrom Separations offers a comprehensive portfolio of products and services, including ZirChrom Phases, Buffer Wizard Software, and HPLC Columns.
Durable zirconia-based phases for efficient chromatographic separations.
Automated calculator for preparing buffers in laboratory settings.
Columns with unique selectivity for LC/MS applications.
Funding Insights of ZirChrom Separations
- Total Rounds 4
- Last Round Grant — $350,000
- First Round $100,000
(Jun 1998)
- Investors Count 2
All 4 funding rounds of ZirChrom Separations with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Aug 2001 | $350,000 | Grant | – | – | |
| Mar 2000 | $750,000 | Grant | – | – | |
| Sep 1999 | $400,000 | Grant | – | – | |
| Jun 1998 | $100,000 | Grant | – | – |
2 investors in total: 2 institutional.
Investors in ZirChrom Separations
ZirChrom Separations has secured backing from 2 investors, including institutional investors. Prominent investors backing the company include NIH and National Science Foundation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
A government-backed foundation providing seed-stage investments to support small businesses. | 1950 | nsf.gov | Arlington, United States | |
Drug discovery services are provided to the biopharma sector. | 1887 | nih.gov | United States |
Investor details for ZirChrom Separations
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
People of ZirChrom Separations
1 people are tracked at ZirChrom Separations (1 in leadership).
| Name | Role | Group |
|---|---|---|
Clayton McNeff | CEO | Leadership |
Complete people profiles for ZirChrom Separations
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Timeline of ZirChrom Separations
3 dated milestones of ZirChrom Separations across 6 years, from founding to its latest funding, stage changes and deals.
- Founded ZirChrom Separations is founded.
- Funding First funding round of $100K.
- Funding Latest funding round, Grant, of $350K.
Competitors of ZirChrom Separations
ZirChrom Separations has 3 listed competitors in our database, 3 of them funded. They include ChromaTan, Sepax Technologies and Semba Biosciences.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| chromatan.com | 2009 | State College, United States | $5.32M | Continuous countercurrent tangential chromatography separation technology is developed. | ||
| sepax-tech.com | 2002 | Newark, United States | $109.24M | 57 | Solutions for chromatographic biomolecular separation are developed and provided. | |
| sembabio.com | 2005 | Madison, United States | $5.85M | Provider of systems for molecular separation based on simulated moving bed chromatography (SMBC) |
Detailed competitors of ZirChrom Separations
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Web traffic of ZirChrom Separations
The website of ZirChrom Separations (zirchrom.com) receives about 2.9K visits a month.
- Monthly visits2.9K
▼ 10.2% vs previous month
Websites whose visitors overlap most with ZirChrom Separations. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
kinesis-solutions.co.uk | kinesis-solutions.co.uk | 100% | – | ||
inertsil.com | inertsil.com | 100% | – | ||
hplcweb.com | hplcweb.com | 100% | – | ||
column-engineering.com | column-engineering.com | 99% | – | ||
| sielc.com | 99% | 41.8K | #822,744 | View details | |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
All 18 similar websites and full traffic analytics for ZirChrom Separations
The complete similar-websites list, audience overlap and engagement analytics require an active premium plan.
- 18 similar websites
- Audience overlap
- Engagement analytics
- Traffic by brand
Verified entity values are shown only after access is granted.
Top companies in Life Sciences Platforms & Tools
3 companies that operate in the same segment as ZirChrom Separations (Life Sciences Platforms & Tools) in United States, ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Medidata is recognized as a leading provider of SaaS solutions for clinical research. | 1999 | New York, New York, United States | USD 41.5 M | |||
AI-based solutions for health management are provided. | 2015 | Dallas, Texas, United States | USD 2.8 B | 1,111 | ||
Real-world health data is provided for research and decisions. | 2012 | Menlo Park, California, United States | USD 259.16 M |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about ZirChrom Separations
ZirChrom Separations was founded in 1995 and raised its 1st funding round 3 years after it was founded.
ZirChrom Separations is headquartered in Anoka, United States. It is registered at Anoka, Minnesota, United States.
Clayton McNeff is the CEO of ZirChrom Separations, as recorded in our data.
ZirChrom Separations is developing and manufacturing Zirconia-based HPLC stationary phases which can be used for analyzing non-volatile compounds in a range of industries. The companys HPLC stationary phases are LC-MS friendly and are ultra-durable zirconia and titania-based and as per company claims, offer unique chromatographic selectivity and high efficiency, low back pressure and excellent pore structure of rigid inorganic supports. The company claims that unlike traditional Silica gel, alumina or polymeric HPLC stationary phases, their Zirconia-based columns are chemically stable over the entire pH range from 1-14, and are also thermally stable. The companys HPLC columns can be used for the analysis of amino acids, peptides, proteins, nucleic acids (RNA and DNA), carbohydrates, pesticides, environmental samples, clinical samples and pharmaceuticals, and others.
ZirChrom Separations's top competitors include ChromaTan, Sepax Technologies and Semba Biosciences.
ZirChrom Separations offers ZirChrom Phases, Buffer Wizard Software, and HPLC Columns.
ZirChrom Separations has 2 investors. Key investors include NIH, and National Science Foundation.
ZirChrom Separations operates through Zirchrom Separations, Inc..